
In this episode, Ted opens with a poem that captures the persistent, compounding burden on clinical trial sites: 50-page consents, non-functional tech, poached CRCs, financial holdbacks, and study designs that ask far too much from participants for far too little payoff. What follows is a candid conversation between Ted and Liam about why these problems haven't gone away and in many cases, have gotten worse. Study visits in 2026 take twice as long as a decade ago. One in three procedur...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Ep 2.30: Scott Burgher on Where AI Actually Helps Patient Recruitment (Part 3/3)

Ep 2.29: "That's Not a Performance Problem, It's a Structural One" Scott Burgher on Why Sites Stop Recruiting (Part 2/3)

Ep 2.28 Scott Burgher on Why 86% of Trials Miss Their Enrollment Deadline (Part 1/3)

Ep 2.27: 31 Years of Clinical Trials, Here's What Ted Trafford Knows for Sure
Free AI-powered recaps of Innovating Clinical Trials and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.